EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Therapeutic Response to PRRNT in a Rare Case of Metastatic Renal Neuroendocrine Carcinoma

Saumya Sara Sunny, Julie Hephzibah, Raju Titus Chacko, Thomas Alex Kodiatte

World Journal of Nuclear Medicine · 01.06.2024 · 23 (02) · 141-146

DOI: 10.1055/s-0044-1785461 ↗

Kurz gefasst

Fallbericht in der Zeitschrift World Journal of Nuclear Medicine, erschienen am 01.06.2024. Verfasst von Saumya Sara Sunny und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Christian Medical College and Hospital, Vellore, Tamil Nadu, India. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroendocrine tumors (NETs) are a rare spectrum of neoplasms that are characterized by neuroendocrine and neural differentiation. The treatment can be challenging in view of the heterogeneity in differentiation and behavior. Primary renal origin NETs are rare and only a few cases have been reported in the literature. There is limited knowledge on their presentation and response to various lines of treatment. We report a case of a patient with a metastatic renal NET from a rare histological subtype of large cell neuroendocrine carcinoma, known to cause aggressive disease with poor prognosis. A multimodality treatment approach was followed. In spite of surgical management and second-line chemotherapy, the disease progressed. The patient subsequently received peptide receptor radionuclide therapy (PRRNT) using lutetium-177 DOTATATE, following which the patient demonstrated a remarkable clinical and radiological response and is stable to date. In a rare tumor with poor prognosis, the relevance of theranostics and the efficacy of targeted therapies like PRRNT are noteworthy.

Schlagwörter

Stichwörter der Autor:innen

DOTATATElutetium-177neuroendocrine tumorspeptide receptor radionuclide therapytheranostics

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
  • Department of Medical Oncology, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
  • Department of Pathology, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.

Zitieren

APA

Sunny, S. S., Hephzibah, J., Chacko, R. T., & Kodiatte, T. A. (2024). Therapeutic Response to PRRNT in a Rare Case of Metastatic Renal Neuroendocrine Carcinoma. World Journal of Nuclear Medicine, 23(02), 141-146. https://doi.org/10.1055/s-0044-1785461

Vancouver

Sunny SS, Hephzibah J, Chacko RT, Kodiatte TA. Therapeutic Response to PRRNT in a Rare Case of Metastatic Renal Neuroendocrine Carcinoma. World Journal of Nuclear Medicine. 2024;23(02):141-146. doi:10.1055/s-0044-1785461

BibTeX
@article{Sunny2024,
  author = {Sunny, Saumya Sara and Hephzibah, Julie and Chacko, Raju Titus and Kodiatte, Thomas Alex},
  title = {Therapeutic Response to PRRNT in a Rare Case of Metastatic Renal Neuroendocrine Carcinoma},
  journal = {World Journal of Nuclear Medicine},
  year = {2024},
  volume = {23},
  number = {02},
  pages = {141--146},
  doi = {10.1055/s-0044-1785461}
}
Kostenlos starten →